CTH, cystathionine gamma-lyase, 1491

N. diseases: 93; N. variants: 5
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 AlteredExpression disease BEFREE Protein steady-state levels of S-adenosylhomocysteine-hydrolase and cystathionine gamma-lyase diminished but methylthioadenosine phosphorylase levels increased in pancreas with acute pancreatitis. 31539805 2020
CUI: C0003504
Disease: Aortic Valve Insufficiency
Aortic Valve Insufficiency
0.010 Biomarker disease BEFREE Lowering endogenous production of H<sub>2</sub> S by concomitant silencing of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). 31017307 2020
CUI: C0003507
Disease: Aortic Valve Stenosis
Aortic Valve Stenosis
0.010 Biomarker disease BEFREE Lowering endogenous production of H<sub>2</sub> S by concomitant silencing of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). 31017307 2020
CUI: C0042341
Disease: Varicocele
Varicocele
0.010 Biomarker disease BEFREE D,L-propargylglycine (PAG) was administrated to show the effects of cystathionine γ-lyase enzyme (CSE) inhibition in the varicocele. 31793716 2020
CUI: C0003578
Disease: Apnea
Apnea
0.010 Biomarker phenotype BEFREE Blocking the CB hyperactivity with L-propargylglycine, an inhibitor of cystathionine-γ-lyase (CSE), which catalyzes H<sub>2</sub>S synthesis, prevented apneas in HO-2<sup>-/-</sup> mice. 30357741 2019
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.010 Biomarker disease BEFREE Cystathionine-γ-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis. 29844591 2019
CUI: C0020550
Disease: Hyperthyroidism
Hyperthyroidism
0.010 AlteredExpression disease BEFREE In this study, we determined the effects of hyperthyroidism on H<sub>2</sub> S levels in various tissues and messenger RNA (mRNA) expression of cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST) in the liver and muscles of the rat. 30825200 2019
CUI: C0024115
Disease: Lung diseases
Lung diseases
0.010 Biomarker group BEFREE Recent studies suggest that hydrogen sulfide (H2S), a gaseous vasodilator generated in the blood vessels by the enzymes cystathionine γ-lyase (CSE) and cystathionine-β-synthase (CBS), could induce the vasodilation, thus improving contraction or remodeling-induced lung diseases. 31356554 2019
CUI: C0032617
Disease: Polyuria
Polyuria
0.010 Biomarker phenotype BEFREE Inhibition of both cystathionine-γ-lyase (CSE) and cystathionine-β-synthase (CBS), 2 major enzymes for endogenous H<sub>2</sub>S production, with propargylglycine (PPG) and amino-oxyacetate (AOAA), respectively, caused increased urine output and reduced urine osmolality in mice that was associated with decreased expression of aquaporin (AQP)-2 in the renal inner medulla. 30036087 2019
CUI: C0154251
Disease: Lipid Metabolism Disorders
Lipid Metabolism Disorders
0.010 Biomarker group BEFREE Cystathionine γ-lyase (CSE; also cystathionase), a principal hydrogen sulfide (H<sub>2</sub>S)-synthesizing enzyme in the liver, is involved in glucose and lipid metabolism disorders. 30526049 2019
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site
0.010 GeneticVariation disease BEFREE We used mice genetically deficient in the cystathionine γ-lyase enzyme (CSE), the major H<sub>2</sub>S-generating enzyme in the lung to determine the contribution of H<sub>2</sub>S to airway disease in response to side-stream tobacco smoke (TS), and to TS/RSV co-exposure. 30986815 2019
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 AlteredExpression disease BEFREE Clinical data further reveal that the expression of CTH is elevated in late-stage prostate cancer patients, and higher CTH expression correlates with poor survival from The Cancer Genome Atlas (TCGA) prostate cancer RNA-seq datasets. 31468690 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 AlteredExpression disease BEFREE Clinical data further reveal that the expression of CTH is elevated in late-stage prostate cancer patients, and higher CTH expression correlates with poor survival from The Cancer Genome Atlas (TCGA) prostate cancer RNA-seq datasets. 31468690 2019
Secondary malignant neoplasm of lymph node
0.010 AlteredExpression disease BEFREE Knockdown of CTH in PC3 cells results in the suppression of tumor growth and distant metastasis, while overexpression of CTH in DU145 cells promotes primary tumor growth and lymph node metastasis in the orthotopic implanted xenograft mouse model. 31468690 2019
CUI: C0699949
Disease: airway disease
airway disease
0.010 GeneticVariation disease BEFREE We used mice genetically deficient in the cystathionine γ-lyase enzyme (CSE), the major H<sub>2</sub>S-generating enzyme in the lung to determine the contribution of H<sub>2</sub>S to airway disease in response to side-stream tobacco smoke (TS), and to TS/RSV co-exposure. 30986815 2019
Cystathionine beta-Synthase Deficiency Disease
0.010 AlteredExpression disease BEFREE Urinary homolanthionine and thiosulfate in CBSD were increased significantly 1.9 and 3 times suggesting higher hydrogen sulfide synthesis by γ-cystathionase and detoxification respectively. 30341787 2019
CUI: C3495426
Disease: Homocysteinemia
Homocysteinemia
0.010 Biomarker disease BEFREE We previously generated mice lacking cystathionine γ-lyase (Cth) as cystathioninuria models and found them to be with cystathioninemia/homocysteinemia. 31319489 2019
CUI: C0004114
Disease: Astrocytoma
Astrocytoma
0.010 AlteredExpression disease BEFREE The present study investigated the effect of cystathionine on astrocytoma (U373) cell proliferation, the activity of γ-cystathionase (CTH) and changes in thiols levels. 29848703 2018
CUI: C0006826
Disease: Malignant Neoplasms
Malignant Neoplasms
0.010 Biomarker group BEFREE Hydrogen sulfide (H<sub>2</sub>S) and the enzymes that synthesize it, cystathionine-b-synthase, cystathionine γ-lyase, and 3-mercaptopyruvate, are increased in different human malignancies. 29970504 2018
CUI: C0017665
Disease: Membranous glomerulonephritis
Membranous glomerulonephritis
0.010 GeneticVariation disease BEFREE In total, two of the clusters contained seed proteins (phenylalanine‑4‑hydroxlylase and cystathionine γ‑lyase) that were associated with MGN based on the CREG network. 30221719 2018
CUI: C0018801
Disease: Heart failure
Heart failure
0.010 Biomarker disease BEFREE Interestingly, CaMKII activity was found to be elevated in CSE knockout (CSE<sup>-/-</sup>) mice as compared to wild type animals and the phosphorylation status of CaMKII appeared to relate to the severity of heart failure. 30195191 2018
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.010 Biomarker disease BEFREE Interestingly, CaMKII activity was found to be elevated in CSE knockout (CSE<sup>-/-</sup>) mice as compared to wild type animals and the phosphorylation status of CaMKII appeared to relate to the severity of heart failure. 30195191 2018
CUI: C0019569
Disease: Hirschsprung Disease
Hirschsprung Disease
0.010 Biomarker disease BEFREE Reduction of hydrogen sulfide synthesis enzymes cystathionine-β-synthase and cystathionine-γ-lyase in the colon of patients with Hirschsprungs disease. 28689885 2018
CUI: C0022665
Disease: Kidney Neoplasm
Kidney Neoplasm
0.010 Biomarker disease BEFREE Knowledge about the expression and thus a role of enzymes that produce endogenous H<sub>2</sub>S - cystathionine-β-synthase, cystathionine γ-lyase and mercaptopyruvate sulfurtransferase - in renal tumors is still controversial. 29793450 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 GeneticVariation phenotype BEFREE Further investigation of the CTH gene in colorectal carcinogenesis with regards to KRAS and BRAF mutations or other molecular characteristics of the tumor may be warranted. 29694444 2018